Published in Cancer Weekly, October 18th, 2005
"This prospective, longitudinal study examined the effects of risk-adapted craniospinal irradiation (CSI) dose and the interactions of dose with age and time from diagnosis on intelligence quotient (IQ) and academic achievement (reading, spelling, and math) among patients treated for MB. Patients received serial neurocognitive testing spanning from 0 to 6.03 years after diagnosis (median, 3.14 years)," scientists in the United States reported.
"The multi-institutional study included 111 patients, who were 3 to 20 years of age at diagnosis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.